Department of Emergency, The Second People's Hospital of Hefei, The Affiliated Hefei Hospital of Anhui Medical University, Hefei, China.
Center of 120 Emergency, Hefei, China.
Scand J Trauma Resusc Emerg Med. 2022 Aug 13;30(1):49. doi: 10.1186/s13049-022-01036-y.
This study was designed to compare the outcomes of standard cardiopulmonary resuscitation (STD-CPR) and combined chest compression and abdominal compression-decompression cardiopulmonary resuscitation (CO-CPR) with a new device following out-of-hospital cardiac arrest (OHCA). Moreover, we investigated whether patient prognosis improved with this combination treatment.
This trial was a single-centre, prospective, randomized trial, and a blinded assessment of the outcomes was performed. A total of 297 consecutive patients with OHCA were initially screened, and 278 were randomized to the STD-CPR group (n = 135) or the CO-CPR group (n = 143). We compared the proportions of patients who achieved a return of spontaneous circulation (ROSC), survived to hospital admission and survived to hospital discharge. In addition, we also performed the Kaplan-Meier analysis with a log-rank test at the end of the follow-up period to compare the survival curves of the two groups.
The differences were not statistically significant in the proportion of patients who achieved ROSC [31/135 (23.0%) versus 35/143 (24.5%)] and survived to hospital admission [28/135 (20.7%) versus 33/143 (23.1%)] between the CO-CPR group and STD-CPR group. However, there was a significant difference in the proportion of patients who survived to hospital discharge [16/135 (11.9%) versus 7/143 (4.9%)] between the two groups. Nine patients (6.7%) in the CO-CPR group and 2 patients (1.4%) in the STD group showed good neurological outcomes according to the cerebral performance category (CPC) scale score, and the difference was statistically significant (P = 0.003). The Kaplan-Meier curves showed that the patients in the CO-CPR group achieved better survival benefits than those in the STD-CPR group at the end of the follow-up period (log-rank P = 0.007).
CO-CPR was more beneficial than STD-CPR in terms of survival benefits in patients who have suffered out-of-hospital cardiac arrest. Trial registration Chinese Clinical Trial Registry, registered number: ChiCTR2100049581 . Registered 30 July 2021- Retrospectively registered. http://www.medresman.org.cn/uc/index.aspx .
本研究旨在比较标准心肺复苏术(STD-CPR)与新型联合胸外按压和腹部按压-减压心肺复苏术(CO-CPR)治疗院外心脏骤停(OHCA)患者的疗效。此外,我们还研究了这种联合治疗是否能改善患者预后。
这是一项单中心、前瞻性、随机临床试验,并对结果进行了盲法评估。共对 297 例 OHCA 患者进行了初步筛选,278 例患者随机分为 STD-CPR 组(n=135)或 CO-CPR 组(n=143)。我们比较了两组患者自主循环恢复(ROSC)、入院存活和出院存活的比例。此外,我们还在随访结束时进行了 Kaplan-Meier 分析和对数秩检验,以比较两组的生存曲线。
CO-CPR 组 ROSC 患者比例[31/135(23.0%)比 STD-CPR 组 35/143(24.5%)]和入院存活患者比例[28/135(20.7%)比 STD-CPR 组 33/143(23.1%)]差异无统计学意义。但两组出院存活患者比例[16/135(11.9%)比 STD-CPR 组 7/143(4.9%)]差异有统计学意义。CO-CPR 组 9 例(6.7%)患者和 STD 组 2 例(1.4%)患者根据脑功能分类(CPC)评分显示神经功能良好,差异有统计学意义(P=0.003)。Kaplan-Meier 曲线显示,在随访结束时,CO-CPR 组患者的生存获益优于 STD-CPR 组(对数秩检验 P=0.007)。
CO-CPR 组在院外心脏骤停患者的生存获益方面优于 STD-CPR 组。